FFA
ADMA icon

Farther Finance Advisors’s ADMA Biologics ADMA Stock Holding History

Farther Finance Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.7K Sell
4,628
-7,204
-61% -$65.7K ﹤0.01% 3454
2026
Q1 		$108K Sell
11,832
-268
-2% -$4.23K ﹤0.01% 2458
2025
Q4 		$221K Buy
12,100
+2,690
+29% +$45.3K ﹤0.01% 1849
2025
Q3 		$138K Buy
9,410
+2,214
+31% +$38K ﹤0.01% 1838
2025
Q2 		$131K Buy
7,196
+4,473
+164% +$91.2K ﹤0.01% 1612
2025
Q1 		$52.9K Buy
2,723
+2,505
+1,149% +$43.3K ﹤0.01% 1869
2024
Q4 		$3.74K Buy
218
+5
+2% +$94 ﹤0.01% 2780
2024
Q3 		$4.26K Buy
213
+193
+965% +$3K ﹤0.01% 2706
2024
Q2 		$231 Hold
20
– – ﹤0.01% 3470
2024
Q1 		$131 Buy
20
+10
+100% +$55 ﹤0.01% 3333
2023
Q4 		$45 Buy
+10
New +$37 ﹤0.01% 3390

Other funds holding ADMA

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Farther Finance Advisors's ADMA Position: Q2 2026 in Review

Farther Finance Advisors reduced its ADMA Biologics (ADMA) stake by 61% in Q2 2026, selling an estimated $65.7K and leaving 4,628 shares worth $38.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3454.

Farther Finance Advisors first reported a position in ADMA in Q4 2023 and has held it in 11 quarters since. The position peaked at $221K in Q4 2025. 62 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Farther Finance Advisors held 4,628 shares of ADMA Biologics worth $38.7K as of Q2 2026.
  • Farther Finance Advisors sold 7,204 ADMA Biologics shares in Q2 2026, an estimated $65.7K.
  • ADMA Biologics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3454 holding.
  • Farther Finance Advisors first reported a position in ADMA Biologics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's ADMA Biologics position peaked at $221K in Q4 2025.
  • 62 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.